title: Quantitative trait loci on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 control variation in levels of T and B lymphocyte subpopulations.
abstract: Lymphocyte subpopulation levels are used for prognosis and monitoring of a variety of human diseases, especially those with an infectious etiology. As a primary step to defining the major gene variation underlying these phenotypes, we conducted the first whole-genome screen for quantitative variation in lymphocyte count, CD4 T cell, CD8 T cell, B cell, and natural killer cell numbers, as well as CD4:CD8 ratio. The screen was performed in 15 of the CEPH families that form the main human genome genetic project mapping resource. Quantitative-trait loci (QTLs) that account for significant proportions of the phenotypic variance of lymphocyte subpopulations were detected on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18. The most significant QTL found was for CD4 levels on chromosome 8 (empirical P=.00005). Two regions of chromosome 4 showed significant linkage to CD4:CD8 ratio (empirical P=.00007 and P=.003). A QTL for the highly correlated measures of CD4 and CD19 levels colocalized at 18q21 (both P=.003). Similarly, a shared region of chromosome 1 was linked to CD8 and CD19 levels (P=.0001 and P=.002, respectively). Several of the identified chromosome regions are likely to harbor polymorphic candidate genes responsible for these important human phenotypes. Their discovery has important implications for understanding the generation of the immune repertoire and understanding immune-system homeostasis. More generally, these data show the power of an integrated human gene-mapping approach for heritable molecular phenotypes, using large pedigrees that have been extensively genotyped.
authors.affiliation: Molecular Immunogenetics Unit, Department of Rheumatology, Division of Medicine, Guy's, King's and St Thomas' School of Medicine, Guy's Hospital, London, United Kingdom. margaret.a.hall@kcl.ac.uk
authors.forename: M A
authors.initials: MA
authors.lastname: Hall
authors.forename: P J
authors.initials: PJ
authors.lastname: Norman
authors.forename: B
authors.initials: B
authors.lastname: Thiel
authors.forename: H
authors.initials: H
authors.lastname: Tiwari
authors.forename: A
authors.initials: A
authors.lastname: Peiffer
authors.forename: R W
authors.initials: RW
authors.lastname: Vaughan
authors.forename: S
authors.initials: S
authors.lastname: Prescott
authors.forename: M
authors.initials: M
authors.lastname: Leppert
authors.forename: N J
authors.initials: NJ
authors.lastname: Schork
authors.forename: J S
authors.initials: JS
authors.lastname: Lanchbury
mesh_terms: D000483:Alleles; D015703:Antigens, CD / Q000032:analysis; D001402:B-Lymphocytes / Q000166:cytology / Q000378:metabolism*; D002874:Chromosome Mapping; D002877:Chromosomes, Human / Q000235:genetics*; D005260:Female; D005434:Flow Cytometry; D019254:Genes, bcl-2 / Q000235:genetics; D006801:Humans; D007694:Killer Cells, Natural / Q000166:cytology / Q000378:metabolism; D015810:Linkage Disequilibrium; D018655:Lymphocyte Count; D016131:Lymphocyte Subsets / Q000166:cytology / Q000378:metabolism*; D008297:Male; D010641:Phenotype; D019655:Quantitative Trait, Heritable; D013601:T-Lymphocytes / Q000166:cytology / Q000378:metabolism*; D014589:Utah
chemical_list: D015703:Antigens, CD